DE69426021T2 - Xamonelin-Tartrat - Google Patents

Xamonelin-Tartrat

Info

Publication number
DE69426021T2
DE69426021T2 DE69426021T DE69426021T DE69426021T2 DE 69426021 T2 DE69426021 T2 DE 69426021T2 DE 69426021 T DE69426021 T DE 69426021T DE 69426021 T DE69426021 T DE 69426021T DE 69426021 T2 DE69426021 T2 DE 69426021T2
Authority
DE
Germany
Prior art keywords
xamonelin
tartrate
hydrogentartrate
thiadiazol
methylpyridine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69426021T
Other languages
English (en)
Other versions
DE69426021D1 (de
Inventor
Linda Marie Osborne
Lisa Ann Shipley
Svend Treppendahl
Torben Guldager Petersen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS
Application granted granted Critical
Publication of DE69426021D1 publication Critical patent/DE69426021D1/de
Publication of DE69426021T2 publication Critical patent/DE69426021T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
DE69426021T 1993-06-04 1994-05-26 Xamonelin-Tartrat Expired - Fee Related DE69426021T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7257293A 1993-06-04 1993-06-04
PCT/DK1994/000205 WO1994029303A1 (en) 1993-06-04 1994-05-26 Heterocyclic chemistry

Publications (2)

Publication Number Publication Date
DE69426021D1 DE69426021D1 (de) 2000-11-02
DE69426021T2 true DE69426021T2 (de) 2001-05-17

Family

ID=22108479

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69426021T Expired - Fee Related DE69426021T2 (de) 1993-06-04 1994-05-26 Xamonelin-Tartrat

Country Status (22)

Country Link
US (1) US5834495A (de)
EP (1) EP0703915B1 (de)
JP (1) JP3190679B2 (de)
KR (1) KR100339115B1 (de)
CN (1) CN1064681C (de)
AT (1) ATE196631T1 (de)
AU (1) AU698673B2 (de)
CA (1) CA2164296C (de)
CZ (1) CZ290550B6 (de)
DE (1) DE69426021T2 (de)
DK (1) DK0703915T3 (de)
ES (1) ES2152315T3 (de)
FI (1) FI955829A (de)
GR (1) GR3035033T3 (de)
HU (1) HUT75038A (de)
IL (1) IL109866A (de)
NO (1) NO305560B1 (de)
NZ (2) NZ267062A (de)
PT (1) PT703915E (de)
SK (1) SK281980B6 (de)
WO (1) WO1994029303A1 (de)
ZA (1) ZA943904B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6043258A (en) * 1996-08-01 2000-03-28 Eli Lilly And Company Method for treating disruptive behavior disorders with xanomeline
EP0821954A1 (de) * 1996-08-01 1998-02-04 Eli Lilly And Company Verfahren zur Behandlung von geistiger Zurückgebliebenheit
US6117890A (en) * 1996-08-01 2000-09-12 Eli Lilly And Company Method for treating bipolar disorder
EP0821956A1 (de) * 1996-08-01 1998-02-04 Eli Lilly And Company Verfahren zur Behandlung disruptiver Verhaltensstörungen
US6090829A (en) * 1996-08-01 2000-07-18 Eli Lilly And Company Method for treating excessive aggression
US6034108A (en) * 1997-07-28 2000-03-07 Eli Lilly And Company Method for treating mental retardation
EP3265128A4 (de) * 2015-03-06 2018-09-12 Chase Pharmaceuticals Corporation Kombination aus transdermalem oxybutynintherapiesystem und muscarinrezeptoragonist

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260311A (en) * 1989-02-22 1993-11-09 Novo Nordisk A/S Piperidine compounds and their use
US5264444A (en) * 1989-02-22 1993-11-23 Novo Nordisk A/S Piperidine compounds and use
US5043345A (en) * 1989-02-22 1991-08-27 Novo Nordisk A/S Piperidine compounds and their preparation and use

Also Published As

Publication number Publication date
CZ290550B6 (cs) 2002-08-14
AU698673B2 (en) 1998-11-05
FI955829A0 (fi) 1995-12-04
EP0703915A1 (de) 1996-04-03
CA2164296C (en) 2007-01-23
NO954892L (no) 1995-12-01
GR3035033T3 (en) 2001-03-30
PT703915E (pt) 2001-03-30
NZ267062A (en) 1999-09-29
IL109866A (en) 2000-06-01
KR100339115B1 (ko) 2002-11-07
HU9503453D0 (en) 1996-01-29
IL109866A0 (en) 1994-10-07
DK0703915T3 (da) 2001-01-22
JPH08511008A (ja) 1996-11-19
HUT75038A (en) 1997-03-28
NZ336733A (en) 2001-02-23
FI955829A (fi) 1995-12-04
CN1064681C (zh) 2001-04-18
WO1994029303A1 (en) 1994-12-22
EP0703915B1 (de) 2000-09-27
NO305560B1 (no) 1999-06-21
ATE196631T1 (de) 2000-10-15
CA2164296A1 (en) 1994-12-22
ES2152315T3 (es) 2001-02-01
NO954892D0 (no) 1995-12-01
CN1128999A (zh) 1996-08-14
JP3190679B2 (ja) 2001-07-23
KR960702835A (ko) 1996-05-23
ZA943904B (en) 1995-12-04
US5834495A (en) 1998-11-10
SK281980B6 (sk) 2001-09-11
AU6924294A (en) 1995-01-03
SK152095A3 (en) 1996-10-02
CZ321095A3 (en) 1996-09-11
DE69426021D1 (de) 2000-11-02

Similar Documents

Publication Publication Date Title
GR1002038B (en) Laparascopic instrument for the application of endoligatures.
DE68908470T2 (de) Weiche wärmeleistungsfähige Zuammensetzung.
NO881697D0 (no) Verktoeyenhet, verktoeydeler og fremgangsmaate for sammensetting av delene.
GB9514473D0 (en) Chemical compounds
FI910851A (fi) 3-arylkarbonyl-1h-indoler anvaendbara som terapeutiska aemnen.
DE69105462T2 (de) Desinfizierende Zusammensetzung.
DE69300694D1 (de) Desinfizierende Zusammensetzungen.
AU4717089A (en) N-(3,4-Dioxy-and N-(4-oxy-3-thio-benzyl)-thioureas
FI941776A0 (fi) Menetelmä 1,2,4-tiadiatsolien valmistamiseksi
DE58902899D1 (de) 2',3'-dideoxypurinnucleosid/purinnucleosid-phosphorylase-inhibitor kombinationstherapie und zusammensetzungen dafuer.
FI893616A0 (fi) Ny anvaendning foer 5-hetero-aryl- eller 5-arylsubstituerade imidazo/2,1-a/ isokinoliner.
NO902548L (no) Fremgangsmaate for fremstilling av fenamat-1,3,4-tiadiazoler og 1,3,4 oksadiazoler.
MY105128A (en) Bu-3608 derivatives.
ATE196631T1 (de) Xamonelin-tartrat
FR2695297B1 (fr) Composition d'agent désinfectant.
EP0038003A3 (de) Pyrrolylpiperidine als Antidepressiva
DE68900131D1 (de) Biozide 4,5-dichlor-1,2-dithiol-3-on-zusammensetzung.
DE68910057D1 (de) Behandlungszusammensetzungen.
FI883268A0 (fi) Engaongssugpaose foer patientsekret.
DE69013332D1 (en) N-(3',4'-dimethoxyzimtsäure)anthranilsäure.
ATE82855T1 (de) 2',3'-dideoxypurinnucleosid/purinnucleosidphosphorylase-inhibitor kombinationstherapie und zusammensetzungen dafuer.
FR2710832B1 (fr) Articulateur dentaire.
EG18688A (en) Biocidal, particularly virudical compositions
AU1512092A (en) Use of 9-amino-1,2,3,4-tetrahydroacridin-1-o1- and related compounds for the treatment of aids
FI913161A0 (fi) Foerfarande foer framstaellning av n-(3',4'-dimetoxikinnamoyl) antranilsyra.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: ELI LILLY AND CO., INDIANAPOLIS, IND., US

8328 Change in the person/name/address of the agent

Representative=s name: SPOTT, WEINMILLER & BOEHM, 80336 MUENCHEN

8328 Change in the person/name/address of the agent

Representative=s name: KROHER, STROBEL RECHTS- UND PATENTANWAELTE, 80336

8339 Ceased/non-payment of the annual fee